Dowling & Yahnke LLC Merck & Co., Inc. Transaction History

Dowling & Yahnke LLC

  • $215 Million
  • Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 105,758 shares of MRK stock, worth $10.5 Million. This represents 4.24% of its overall portfolio holdings.

Number of Shares
105,758
Previous 105,658 0.09%
Holding current value
$10.5 Million
Previous $9.63 Million 5.45%
% of portfolio
4.24%
Previous 0.45%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
BUY
$84.53 - $94.96 $8,453 - $9,496
100 Added 0.09%
105,758 $9.11 Million
Q2 2022

Aug 10, 2022
BUY
$83.49 - $94.64 $48,507 - $54,985
581 Added 0.55%
105,658 $9.63 Million
Q1 2022

May 04, 2022
BUY
$73.51 - $82.4 $52,559 - $58,916
715 Added 0.69%
105,077 $8.62 Million
Q4 2021

Feb 10, 2022
SELL
$72.28 - $90.54 $128,513 - $160,980
-1,778 Reduced 1.68%
104,362 $8 Million
Q3 2021

Nov 12, 2021
SELL
$71.68 - $78.83 $68,167 - $74,967
-951 Reduced 0.89%
106,140 $7.97 Million
Q2 2021

Jul 21, 2021
BUY
$70.31 - $77.77 $138,510 - $153,206
1,970 Added 1.87%
107,091 $8.33 Million
Q1 2021

Apr 29, 2021
SELL
$68.86 - $81.11 $89,173 - $105,037
-1,295 Reduced 1.22%
105,121 $8.1 Million
Q4 2020

Jan 28, 2021
BUY
$71.77 - $79.65 $415,404 - $461,014
5,788 Added 5.75%
106,416 $8.71 Million
Q3 2020

Oct 19, 2020
BUY
$73.18 - $82.95 $18,807 - $21,318
257 Added 0.26%
100,628 $8.35 Million
Q2 2020

Jul 31, 2020
BUY
$70.42 - $80.13 $43,167 - $49,119
613 Added 0.61%
100,371 $7.76 Million
Q1 2020

May 15, 2020
SELL
$63.36 - $87.82 $180,195 - $249,760
-2,844 Reduced 2.77%
99,758 $7.68 Million
Q4 2019

Jan 27, 2020
SELL
$77.58 - $87.54 $200,854 - $226,641
-2,589 Reduced 2.46%
102,602 $9.33 Million
Q3 2019

Oct 29, 2019
BUY
$76.08 - $82.93 $261,563 - $285,113
3,438 Added 3.38%
105,191 $8.86 Million
Q2 2019

Jul 22, 2019
SELL
$69.84 - $81.59 $109,020 - $127,361
-1,561 Reduced 1.51%
101,753 $8.53 Million
Q1 2019

Apr 30, 2019
BUY
$69.58 - $79.36 $228,848 - $261,015
3,289 Added 3.29%
103,314 $8.59 Million
Q4 2018

Jan 24, 2019
BUY
$65.24 - $75.71 $130,806 - $151,798
2,005 Added 2.05%
100,025 $7.94 Million
Q3 2018

Oct 30, 2018
SELL
$57.69 - $67.84 $86,477 - $101,692
-1,499 Reduced 1.51%
98,020 $6.95 Million
Q2 2018

Jul 30, 2018
SELL
$50.83 - $59.72 $66,282 - $77,874
-1,304 Reduced 1.29%
99,519 $6.04 Million
Q1 2018

May 01, 2018
SELL
$50.96 - $59.23 $62,731 - $72,912
-1,231 Reduced 1.21%
100,823 $5.49 Million
Q4 2017

Feb 02, 2018
SELL
$51.62 - $61.64 $5.49 Million - $6.55 Million
-106,322 Closed
0 $0
Q3 2017

Nov 08, 2017
BUY
$58.67 - $63.13 $6.24 Million - $6.71 Million
106,322
106,322 $6.81 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Dowling & Yahnke LLC Portfolio

Follow Dowling & Yahnke LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email